Acyclovir
Treatment for Meningitis
Typical Dosage: 10 mg/kg IV every 8 hours
Effectiveness
90%
Safety Score
75%
Clinical Trials
2
Participants
30K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
75
DangerousModerateSafe
Treatment Details
Dosage Range
10 mg/kg IV every 8 hours
Time to Effect
immediate
Treatment Duration
14-21 days
Evidence Quality
HIGHNumber Needed to Treat (NNT)
3(Treat 3 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$350
Monitoring:$750
Side Effect Mgmt:$150
Total Annual:$1,250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
8
Outcome-Based Costs
Cost per Responder
$1,471
Cost per Remission
$1,667
Acyclovir Outcomes
for Meningitis
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+85%
Remission Rate
+75%
Common Side Effects
Nausea/Vomiting/Diarrhea
+8%
Headache
+7%
Renal dysfunction (IV, high dose)
+3%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
1 active trial recruiting for Acyclovir in Meningitis
Aciclovir Versus Placebo for HSV-2 Meningitis
NCT05452928NOT YET RECRUITINGPHASE4
150 participants
INTERVENTIONAL
Started: Jun 1, 2026